AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Abpride-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Ampiron Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Abpride-M2 Tablet ER

Diabetace Duo ER tablets are an antidiabetic medication combining two agents for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Always take Diabetace Duo ER with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and manage them accordingly, maintaining regular meals and carrying fast-acting glucose sources (e.g., sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any prior heart conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring, along with potential blood tests for blood cell counts and liver function, will be recommended by your doctor.

Uses of Abpride-M2 Tablet ER

Managing type 2 diabetes

Major Benefits of Abpride-M2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Abpride-M2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Abpride-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Abpride-M2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Abpride-M2 Tablet ER with a meal.

How Abpride-M2 Tablet ER works:

Abpride-M2 Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Abpride-M2 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Abpride-M2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Abpride-M2 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Abpride-M2 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Abpride-M2 Tablet ER use. Physician consultation is recommended. Routine kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Abpride-M2 Extended-Release tablets cautiously, potentially requiring dosage modifications. Consultation with a physician is advised. For individuals with mild to moderate liver disease, Abpride-M2 ER therapy typically begins with a low dose; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Abpride-M2 Tablet ER :

Should you forget a dose of Abpride-M2 Extended-Release Tablets, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Abpride-M2 Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Abpride-M2 Tablet ER

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Abpride-M2 Tablet ER use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Abpride-M2 Tablet ER and prompt medical attention.
Abpride-M2 Extended-Release tablets contain glimepiride and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This therapy enhances glycemic control when combined with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Taking Abpride-M2 Tablet ER may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Abpride-M2 Tablet ER use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities), weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive strategies proposed by some studies include supplemental Vitamin B12 administration at least annually.
Indeed, Abpride-M2 Tablet ER can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, increased hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk is heightened by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It's advisable to carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Abpride-M2 Tablet ER and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Abpride-M2 Tablet ER
170
MRP 207
17% off